APAP 500 mg Acetaminophen Recalled Due to CGMP Deviations
ULTRAtab Laboratories is recalling APAP 500 mg SRC Coated tablets in bulk due to manufacturing process deviations. The company voluntarily initiated the Class II recall on January 26, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for CGMP deviations without reported illnesses or injuries. The source text contains no evidence of harm or contamination—only manufacturing process compliance issues—placing this recall at the Moderate level per the rubric.
Plain-English summary
ULTRAtab Laboratories, Inc., of Highland, New York, is recalling APAP 500 mg SRC Coated (Acetaminophen 500 mg) tablets distributed in bulk containers. The recall affects approximately 18.8 million tablets with product code L211L and bulk lot numbers 18M043, 18M044, 18M045, 19B032, 19B033, 19B034, 19F008, 19F009, and 19F010 (NDC 62959-211-00).
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturer's processes. The bulk product was distributed to 3 distributors, who may have further distributed finished product containing these tablets.
This is a voluntary Class II recall initiated by the firm on January 26, 2022, and terminated on January 7, 2025. The FDA notified the firm by letter on February 9, 2022. Consumers or healthcare providers who have this product should contact their distributor or the manufacturer for return instructions.
The recalled product
- Product
- APAP 500 mg SRC Coated (Acetaminophen 500 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-211-00
- Manufacturer
- ULTRAtab Laboratories, Inc.
- Category
- Drug — Acetaminophen
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Product Codes: L211L Bulk Lots: 18M043
- 18M044
- 18M045
- 19B032
- 19B033
- 19B034
- 19F008
- 19F009
- 19F010
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27